Product Program year 2025 Source: CMS Open Payments

Qfitlia

Drug

Open in the dashboard

General payments

$295,307

294 payments

Research payments

$411,320

132 payments

Through program year 2025, $295,307 in general payments and $411,320 in research payments were reported against Qfitlia.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $295,307 294
2025 Research $411,320 132

Breakdown

Who paid General payments · program year 2025
  1. Genzyme Corporation $284,384 292 payments
  2. Sanofi US Services Inc. $10,923 2 payments
Top recipients General payments · program year 2025
  1. Abdullah Kutlar Hematology & Oncology · Augusta, GA $13,767 5% · 5 payments
  2. Steven Lentz Hematology · Iowa City, IA $13,231 4% · 7 payments
  3. Madhvi Rajpurkar Pediatrics · Detroit, MI $12,885 4% · 7 payments
  4. Oladipo Cole Hematology & Oncology · Farmington, CT $11,608 4% · 4 payments
  5. Mindy Simpson Pediatrics · Chicago, IL $11,392 4% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Pediatric Hematology-Oncology Pediatrics $94,557 32% · 34 practitioners
  2. Hematology & Oncology Internal Medicine $61,458 21% · 15 practitioners
  3. Pediatrics $24,438 8% · 7 practitioners
  4. Hematology Internal Medicine $22,270 8% · 7 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $21,817 7% · 9 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Florida $37,639 13% · 9 recipients
  2. Pennsylvania $27,671 9% · 6 recipients
  3. Texas $25,021 8% · 6 recipients
  4. California $23,856 8% · 14 recipients
  5. Georgia $23,630 8% · 10 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

294 general · 132 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record